- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (493)
- Timeline of Article Publication (11)
- Authors Evaluation (3)
- Article Quality Tracking (0)
- Reference Citation Analysis (6)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13205)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang KY, Wang FY, Lv M, Ma XX, Tang XD, Lv L. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023; 29(26): 4120-4135 [PMID: 37475846 DOI: 10.3748/wjg.v29.i26.4120] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4120.htm |
| Number | Citing Articles |
| 1 |
Ploutarchos Pastras, Ioanna Aggeletopoulou, Christos Triantos. Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options. Microorganisms 2024; 12(10): 2036 doi: 10.3390/microorganisms12102036
|
| 2 |
Sulaiman A Alshammari, Mohsen N Almutairi, Mohammad O Alomar, Ziyad M Alsherif, Faisal H Alsubaie, Abdulrahman I Almezaini. Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life. Cureus 2023; doi: 10.7759/cureus.50840
|
| 3 |
I.Ya. Hospodarskyy, L.A. Hryshchuk, T.V. Boyko. The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection. GASTROENTEROLOGY 2024; 58(2): 121 doi: 10.22141/2308-2097.58.2.2024.605
|
| 4 |
C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone. Inflammatory bowel diseases and spondyloarthritis: a focus on female patients. Reumatismo 2024; 76(3) doi: 10.4081/reumatismo.2024.1770
|
| 5 |
Sohel S. Shaikh, Sanjay Kumar. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. Medicine 2024; 103(31): e39134 doi: 10.1097/MD.0000000000039134
|
| 6 |
Christian Lambiase, Alessandra Rossi, Riccardo Morganti, Lorenzo Cancelli, Antonio Grosso, Riccardo Tedeschi, Francesco Rettura, Marta Mosca, Nicola de Bortoli, Massimo Bellini. Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes. Nutrients 2024; 16(19): 3419 doi: 10.3390/nu16193419
|
| 7 |
Carolina Marques Lopes, Cristina Sofia de Jesus Monteiro, Ana Paula Duarte, Jorge Luiz dos Santos. Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review. Journal of Clinical Medicine 2024; 13(21): 6337 doi: 10.3390/jcm13216337
|
| 8 |
Na-Ri Choi, Seok-Jae Ko, Joo-Hyun Nam, Woo-Gyun Choi, Jong-Hwan Lee, Seung-Yeol Nah, Jae-Woo Park, Byung-Joo Kim. Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. Pharmaceuticals 2024; 17(9): 1170 doi: 10.3390/ph17091170
|
| 9 |
Jun Zhao, Xia Li, Jiayi Yang, Xin Hao, Junjian Tian, Xin Wang, Xuefei Wang, Ning Li, Zhigang Li. Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study. BMJ Open 2023; 13(12): e079874 doi: 10.1136/bmjopen-2023-079874
|
| 10 |
Hongxiu Chen, Zhifang Xu, Honggang Zhao, Jiazhen Cao, Rui Wang, Jing He, Ru Nie, Jialin Jia, Shuting Yuan, Yonghong Li, Zhicheng Liu, Xinyu Zhang, Lijuan Ha, Xiaoru Xu, Tie Li. Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01396-y
|
| 11 |
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(5): 307 doi: 10.1080/17425255.2024.2348488
|
| 12 |
Vlad Alexandru Ionescu, Gina Gheorghe, Teodor Florin Georgescu, Nicolae Bacalbasa, Florentina Gheorghe, Camelia Cristina Diaconu. The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome. Journal of Clinical Medicine 2024; 13(17): 5124 doi: 10.3390/jcm13175124
|
| 13 |
Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate. Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability. European Journal of Internal Medicine 2024; 125: 10 doi: 10.1016/j.ejim.2024.03.011
|
| 14 |
Omid Vakili, Peyman Adibi Sedeh, Morteza Pourfarzam. Metabolic biomarkers in irritable bowel syndrome diagnosis. Clinica Chimica Acta 2024; 560: 119753 doi: 10.1016/j.cca.2024.119753
|
| 15 |
Bernhard Uehleke, Martin Storr, Martin Hörning. Grapefruit Seed Extract Reduces Gastrointestinal
Symptoms. Zeitschrift für Phytotherapie 2024; 45(02): 54 doi: 10.1055/a-2194-2206
|
| 16 |
清辉 杜. Exploring Treatment Strategies for Irritable Bowel Syndrome Based on the Concept of “Lung Being Connected with Large Intestine”. Advances in Clinical Medicine 2024; 14(09): 131 doi: 10.12677/acm.2024.1492439
|
| 17 |
Kai-Yue Huang, Jia-Yan Hu, Mi Lv, Feng-Yun Wang, Xiang-Xue Ma, Xu-Dong Tang, Lin Lv. Cerebral cortex changes in FD, IBS, and GERD: A Mendelian randomization study. Journal of Affective Disorders 2025; 369: 1153 doi: 10.1016/j.jad.2024.10.057
|
| 18 |
Alexey M. Osadchuk, Irina D. Loranskaya, Mikhail A. Osadchuk. Comorbid functional pathology in gastroenterology. Possibilities and prospects for drug treatment: A review. Consilium Medicum 2024; 25(12): 844 doi: 10.26442/20751753.2023.12.202529
|
| 19 |
Wei-Hao Chai, Yan Ma, Jia-Jia Li, Fei Guo, Yi-Zhan Wu, Jiang-Wei Liu. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World Journal of Clinical Cases 2024; 12(17): 3094-3104 doi: 10.12998/wjcc.v12.i17.3094
Abstract(179) |
Core Tip(193) |
Full Article(HTML)(1066)
|
Full Article with Cover (PDF)-9912K(38)
|
Full Article (Word)-1350K(1)
|
Audio-684K(2)
|
Peer-Review Report-195K(20)
|
Answering Reviewers-104K(17)
|
Full Article (PDF)-9454K(37)
|
Full Article (XML)-117K(19)
|
Times Cited (0)
|
Total Visits (2529)
|
Open
|
| 20 |
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, Jakub Fichna. Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2024; 25(8): 1039 doi: 10.1080/14656566.2024.2366993
|
| 21 |
Michele Linsalata, Antonia Ignazzi, Benedetta D’Attoma, Giuseppe Riezzo, Domenica Mallardi, Antonella Orlando, Laura Prospero, Maria Notarnicola, Valentina De Nunzio, Giuliano Pinto, Francesco Russo. Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet. Nutrients 2024; 16(16): 2706 doi: 10.3390/nu16162706
|